The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Open accessPublished version of a preprint
Abstract
Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness. Since SARS-CoV was first identified in animal markets, global viromics projects have discovered thousands of coronavirus sequences in diverse animals and geographic regions. Unfortunately, there are few tools available to functionally test these viruses for their ability to infect humans, which has severely hampered efforts to predict the next zoonotic viral outbreak. Here, we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent SARS-CoV-2, for receptor usage and their ability to infect cell types from different species. We show that host protease processing during viral entry is a significant barrier for several lineage B viruses and that bypassing this barrier allows several lineage B viruses to enter human cells through an unknown receptor. We also demonstrate how different lineage B viruses can recombine to gain entry into human cells, and confirm that human ACE2 is the receptor for the recently emerging SARS-CoV-2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SARS-CoV-2 is a single-stranded RNA β-coronavirus and a member of the subgenus Sarbecovirus (beta-CoV lineage B).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The S protein mediates binding of coronaviruses to angiotensin converting enzyme 2 (ACE2) on the surface of various cell types including epithelial cells of the pulmonary alveolus (4–6).”
From An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“it directly interacts with the cellular receptor angiotensin converting enzyme 2 (ACE2) which mediates host cell entry”
From SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2 (2021) · cites this paper as Letko et al., 2020
In the citing paper
“It is the seventh member of the Coronaviridae known to infect humans so far, two of which, SARS-CoV and MERS-CoV, caused global health threats previously (Guarner, 2020; Letko et al., 2020).”
From Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection (2020) · cites this paper as Letko et al., 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341
Structure, Function, and Evolution of Coronavirus Spike Proteins
Li, F. (2016) · Annual Review of Virology · doi:10.1146/annurev-virology-110615-042301 · Cited by 2,740
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
Lau, S. K. P., Woo, P. C. Y., Li, K. S. M., Huang, Y. P., Tsoi, H., Wong, B. H. L., Wong, S. S. Y., Leung, S.-Y., Chan, K., & Yuen, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506735102 · Cited by 1,561
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,076
Cited by
Sorted by citations
Items 501–600 of 1,005
Jangra, S., Vrieze, J. D., Choi, A., Rathnasinghe, R., Laghlali, G., Uvyn, A., Herck, S. V., Nuhn, L., Deswarte, K., Zhong, Z., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202015362 · Cited by 77
Overview of the pathogenesis of COVID‑19 (Review)
Li, C., He, Q., Qian, H., & Liu, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10444 · Cited by 90
Li, S., Yang, S., Zhou, Y., Disoma, C., Dong, Z., Du, A., Zhang, Y., Chen, Y., Huang, W., Chen, J., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.712081 · Cited by 80
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
Mast, F. D., Fridy, P. C., Ketaren, N. E., Wang, J., Jacobs, E. Y., Olivier, J. P., Sanyal, T., Molloy, K. R., Schmidt, F., Rutkowska, M., et al. (2021) · eLife · doi:10.7554/elife.73027 · Cited by 69
Structural and functional analysis of a potent sarbecovirus neutralizing antibody
Pinto, D., Park, Y., Beltramello, M., Walls, A. C., Tortorici, M. A., Bianchi, S., Jaconi, S., Culap, K., Zatta, F., Marco, A. D., et al. (2020) · Worldwide Protein Data Bank · doi:10.2210/pdb6ws6/pdb · Cited by 82
Karuppan, M. K. M., Devadoss, D., Nair, M. G., Chand, H. S., & Lakshmana, M. K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02245-1 · Cited by 79
Affinity Sensors for the Diagnosis of COVID-19
Drobysh, M., Ramanavičienė, A., Viter, R., & Ramanavičius, A. (2021) · Micromachines · doi:10.3390/mi12040390 · Cited by 75
Parker, R., Partridge, T., Wormald, C., Kawahara, R., Stalls, V., Aggelakopoulou, M., Parker, J., Doherty, R. P., Ariosa-Morejon, Y., Lee, E., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109179 · Cited by 75
SARS-CoV-2-Impedimetric Biosensor: Virus-Imprinted Chips for Early and Rapid Diagnosis
Hussein, H. A., Kandeil, A., Gomaa, M. R., Nashar, R. M. E., El-sherbiny, I. M., & Hassan, R. Y. A. (2021) · ACS Sensors · doi:10.1021/acssensors.1c01614 · Cited by 78
The coronavirus recombination pathway
Wells, H., Bonavita, C. M., Navarrete‐Macias, I., Vilchez, B., Rasmussen, A. L., & Anthony, S. J. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.05.003 · Cited by 75
Seyedpour, S., Khodaei, B., Loghman, A. H., Seyedpour, N., Kisomi, M. F., Balibegloo, M., Nezamabadi, S. S., Gholami, B., Saghazadeh, A., & Rezaei, N. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30032 · Cited by 74
Pregnancy and COVID ‐19: pharmacologic considerations
D'Souza, R. D., Ashraf, R., Rowe, H., Zipursky, J. S., Clarfield, L., Maxwell, C. V., Arzola, C., Lapinsky, S. E., Paquette, K., Murthy, S., et al. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23116 · Cited by 80
CRISPR-Cas System: An Approach With Potentials for COVID-19 Diagnosis and Therapeutics
Kumar, P., Malik, Y. S., Ganesh, B., Rahangdale, S., Saurabh, S., Natesan, S., Srivastava, A., Sharun, K., Yatoo, M. I., Tiwari, R., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.576875 · Cited by 76
Francés‐Monerris, A., Hognon, C., Miclot, T., García‐Iriepa, C., Iriepa, I., Terenzi, A., Grandemange, S., Barone, G., Marazzi, M., & Monari, A. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00779 · Cited by 72
Evaluation of current diagnostic methods for COVID-19
Alpdağtaş, S., Ilhan, E., Uysal, E., Şengör, M., Üstündağ, C. B., & Gündüz, O. (2020) · APL Bioengineering · doi:10.1063/5.0021554 · Cited by 76
Baindara, P., Chakraborty, R., Holliday, Z. M., Mandal, S. M., & Schrum, A. G. (2021) · New Microbes and New Infections · doi:10.1016/j.nmni.2021.100837 · Cited by 76
SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
Khan, A., Khan, T., Ali, S., Aftab, S., Wang, Y., Wang, Q., Khan, M., Suleman, M., Ali, S., Heng, W., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112176 · Cited by 75
Role of genomics in combating COVID-19 pandemic
Saravanan, K. A., Panigrahi, M., Kumar, H., Rajawat, D., Nayak, S. S., Bhushan, B., & Dutt, T. (2022) · Gene · doi:10.1016/j.gene.2022.146387 · Cited by 81
Abdelmageed, M. I., Abdelmoneim, A. H., Mustafa, M. I., Elfadol, N. M., Murshed, N. S., Shantier, S. W., & Makhawi, A. M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.04.934232 · Cited by 74
Coronavirus entry: how we arrived at SARS-CoV-2
Whittaker, G. R., Daniel, S., & Millet, J. K. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.02.006 · Cited by 67
Qiang, X., Xu, P., Fang, G., Liu, W., & Kou, Z. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00649-8 · Cited by 73
The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm
Chau, A. S., Weber, A. G., Maria, N. I., Narain, S., Liu, A., Hajizadeh, N., Malhotra, P., Bloom, O., Marder, G. S., & Kaplan, B. M. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41526 · Cited by 75
The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
Ye, Z., Harmon, J., Ni, W., Li, Y., Wich, D., & Xu, Q. (2023) · ACS Nano · doi:10.1021/acsnano.2c12584 · Cited by 72
SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profilesPreprint
Bojková, D., McGreig, J. E., McLaughlin, K.-M., Masterson, S. G., Widera, M., Krähling, V., Ciesek, S., Wass, M. N., Michaelis, M., & Cinatl, J. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.03.024257 · Cited by 73
Paola, L. D., Hadi‐Alijanvand, H., Song, X., Hu, G., & Giuliani, A. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00273 · Cited by 71
Karp, D. G., Danh, K., Fonseca, N., Seftel, D., Robinson, P. V., & Tsai, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-76913-6 · Cited by 73
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
Tada, T., Fan, C., Chen, J., Kaur, R., Stapleford, K. A., Gristick, H. B., Dcosta, B. M., Wilen, C. B., Nimigean, C. M., & Landau, N. R. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108528 · Cited by 72
COVID 19-Induced Smell and Taste Impairments: Putative Impact on Physiology
Meunier, N., Briand, L. V., Jacquin, A., Brondel, L., & Pénicaud, L. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.625110 · Cited by 77
Pantazi, I., Al-Qahtani, A. A., Alhamlan, F. S., Alothaid, H., Matou‐Nasri, S., Sourvinos, G., Vergadi, E., & Tsatsanis, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683800 · Cited by 74
Yang, R., Huang, B., A, R., Li, W., Wang, W., Deng, Y., & Tan, W. (2020) · Biosafety and Health · doi:10.1016/j.bsheal.2020.08.004 · Cited by 70
Wehbe, Z., Hammoud, S. H., Soudani, N., Zaraket, H., EL‐Yazbi, A. F., & Eid, A. H. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00836 · Cited by 71
Turski, W. A., Wnorowski, A., Turski, G. N., Turski, C. A., & Turski, L. (2020) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-201042 · Cited by 73
Relación entre COVID-19 y síndrome de Guillain-Barré en adultos. Revisión sistemática
Gittermann, L. M. T., Feris, S. V., & Astrid von Oetinger, G. (2020) · Neurología · doi:10.1016/j.nrl.2020.07.004 · Cited by 83
Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System
Costa, L. B., Perez, L. G., Palmeira, V. A., Cordeiro, T. M. E., Ribeiro, V. T., Lanza, K., & Silva, A. C. S. E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559841 · Cited by 71
SARS-CoV-2 reinfection and implications for vaccine development
Nainu, F., Abidin, R. S., Bahar, M. A., Frediansyah, A., Emran, T. B., Rabaan, A. A., Dhama, K., & Harapan, H. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1830683 · Cited by 73
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
Shukla, A. K., & Banerjee, M. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00439-9 · Cited by 76
Chiodo, F., Bruijns, S. C. M., Rodríguez, E., Li, R. J. E., Molinaro, A., Silipo, A., Lorenzo, F. D., García-Rivera, D., Valdés-Balbín, Y., Vérez-Bencomo, V. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.13.092478 · Cited by 73
Bibliometric analysis of global scientific research on Coronavirus (COVID-19).
Dehghanbanadaki, H., Seif, F., Vahidi, Y., Razi, F., Hashemi, E., Khoshmirsafa, M., & Aazami, H. (2020) · PubMed Central · doi:10.34171/mjiri.34.51 · Cited by 70
Cell-Mediated Immune Responses to COVID-19 Infection
Guihot, A., Litvinova, E., Autran, B., Debré, P., & Vieillard, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01662 · Cited by 70
Perspective: The Potential Effects of Naringenin in COVID-19
Alberca, R. W., Teixeira, F. M. E., Beserra, D. R., de Oliveira, E. A., Andrade, M. M. D. S., Pietrobon, A. J., & Sato, M. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.570919 · Cited by 73
Krishnan, A., Hamilton, J. P., Alqahtani, S. A., & Woreta, T. A. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02616-5 · Cited by 75
Tracing the origins of SARS-COV-2 in coronavirus phylogenies: a review
Sallard, E., Halloy, J., Casañe, D., Decroly, É., & van Helden, J. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-020-01151-1 · Cited by 79
Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
Kim, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.590509 · Cited by 70
Schepens, B., van Schie, L., Nerinckx, W., Roose, K., Breedam, W. V., Fijałkowska, D., Devos, S., Weyts, W., Cae, S. D., Vanmarcke, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abi7826 · Cited by 66
Tackling SARS-CoV-2: Proposed Targets and Repurposed Drugs
Joshi, S. S., Joshi, M., & Degani, M. S. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0147 · Cited by 68
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
Omolo, C. A., Soni, N., Fasiku, V. O., Mackraj, I., & Govender, T. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173348 · Cited by 69
Tackling COVID-19 pandemic through nanocoatings: Confront and exactitude
Kumar, P., Usmani, Z., Thakur, V. K., Gupta, V. K., & Mishra, Y. K. (2020) · Current Research in Green and Sustainable Chemistry · doi:10.1016/j.crgsc.2020.100011 · Cited by 69
Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2
Dong, J., Huang, B. C. B., Wang, B., Titong, A., Kankanamalage, S. G., Jia, Z., Wright, M., Parthasarathy, P., & Liu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-74761-y · Cited by 67
Calcagnile, M., Forgez, P., Iannelli, A., Bucci, C., Alifano, M., & Alifano, P. (2020) · Biochimie · doi:10.1016/j.biochi.2020.11.004 · Cited by 69
Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-19
Casagrande, M. K., Fitzek, A., Spitzer, M. S., Püschel, K., Glatzel, M., Krasemann, S., Nörz, D. S., Lütgehetmann, M., Pfefferle, S., & Schultheiß, M. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.6339 · Cited by 67
Vitamin D and COVID-19: An Overview of Recent Evidence
Ghelani, D. P., Alesi, S., & Mousa, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910559 · Cited by 71
An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines
Seifert, S. N., Bai, S., Fawcett, S., Norton, E. B., Zwezdaryk, K. J., Robinson, J. E., Gunn, B. M., & Letko, M. C. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010828 · Cited by 63
Self-citationGenetic Spectrum and Distinct Evolution Patterns of SARS-CoV-2
Liu, S., Shen, J., Fang, S., Li, K., Liu, J., Yang, L., Hu, C., & Wan, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.593548 · Cited by 63
Islam, M. M., & Koirala, D. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.339338 · Cited by 68
SARS‐CoV‐2 infection in children – Understanding the immune responses and controlling the pandemic
Lü, X., Xiang, Y., Du, H., & Wong, G. (2020) · Pediatric Allergy and Immunology · doi:10.1111/pai.13267 · Cited by 69
Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2
Longhitano, L., Tibullo, D., Giallongo, C., Lazzarino, G., Tartaglia, N., Galimberti, S., Volti, G. L., Palumbo, G. A., & Liso, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103622 · Cited by 68
2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
Forrestall, K. L., Burley, D. E., Cash, M. K., Pottie, I. R., & Darvesh, S. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109348 · Cited by 68
Synergistic Inhibition of SARS-CoV‑2 Replication Using Disulfiram/Ebselen and Remdesivir
Chen, T., Fei, C., Chen, Y., Sargsyan, K., Chang, C., Yuan, H. S., & Lim, C. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00022 · Cited by 67
Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin
Niu, S., Wang, J., Bai, B., Wu, L., Zheng, A., Chen, Q., Du, P., Han, P., Zhang, Y., Jia, Y., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021107786 · Cited by 67
Cooper, S. L., Boyle, E., Jefferson, S. R., Heslop, C., Mohan, P., Mohanraj, G. G. J., Sidow, H. A., Tan, R. C. P., Hill, S. J., & Woolard, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158255 · Cited by 70
Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection
Allegretti, M., Cesta, M. C., Zippoli, M., Beccari, A. R., Talarico, C., Mantelli, F., Bucci, E. M., Scorzolini, L., & Nicastri, E. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00844-6 · Cited by 67
The Infectious Disease Ontology in the age of COVID-19
Babcock, S., Beverley, J. R., Cowell, L. G., & Smith, B. (2021) · Journal of Biomedical Semantics · doi:10.1186/s13326-021-00245-1 · Cited by 75
Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine
Bonam, S. R., Muller, S., Bayry, J., & Klionsky, D. J. (2020) · Autophagy · doi:10.1080/15548627.2020.1779467 · Cited by 68
Genetic and structural basis for recognition of SARS-CoV-2 spike protein by a two-antibody cocktail
Dong, J., Zost, S. J., Greaney, A. J., Starr, T. N., Dingens, A. S., Chen, E. C., Chen, R. E., Case, J. B., Sutton, R. E., Gilchuk, P., et al. (2021) · doi:10.1101/2021.01.27.428529 · Cited by 55
COVID‐19 with dermatologic manifestations and implications: An unfolding conundrum
Almutairi, N., & Schwartz, R. A. (2020) · Dermatologic Therapy · doi:10.1111/dth.13544 · Cited by 65
Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review
Das, S., Anu, K. R., Birangal, S., Nikam, A. N., Pandey, A. P., Mutalik, S., & Joseph, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118202 · Cited by 69
Hu, J., Jolkkonen, J., & Zhao, C. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.012 · Cited by 69
Abo, K. M., Ma, L., Matte, T. M., Huang, J., Alysandratos, K., Werder, R. B., Mithal, A., Beermann, M. L., Lindstrom-Vautrin, J., Mostoslavsky, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.03.132639 · Cited by 66
Coronavirus Disease: A Review of a New Threat to Public Health
Ramphul, K., & Mejias, S. G. (2020) · Cureus · doi:10.7759/cureus.7276 · Cited by 69
Back to the spring of 2020: facts and hope of COVID-19 outbreak
Zhou, G., Chen, S., & Zhu, C. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0758-9 · Cited by 65
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
Gónzález‐Candelas, F., Shaw, M., Phan, T. G., Kulkarni‐Kale, U., Paraskevis, D. N., Luciani, F., Kimura, H., & Sironi, M. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104869 · Cited by 65
Establishment of an African green monkey model for COVID-19Preprint
Woolsey, C. B., Borisevich, V., Prasad, A. N., Agans, K. N., Deer, D. J., Dobias, N. S., Heymann, J. C., Foster, S. L., Levine, C. B., Medina, L. O., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.17.100289 · Cited by 65
Alexander, S. P. H., Armstrong, J. F., Davenport, A. P., Davies, J. A., Faccenda, E., Harding, S. D., Levi‐Schaffer, F., Maguire, J. J., Pawson, A. J., Southan, C., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15094 · Cited by 61
Coagulopathy in COVID-19: Focus on vascular thrombotic events
Shi, W., Lv, J., & Lin, L. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.07.003 · Cited by 65
Darwesh, A. M., Bassiouni, W., Sosnowski, D. K., & Seubert, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107703 · Cited by 66
Fang, D., Peng, J., Liao, S., Tang, Y., Cui, W., Yuan, Y., Wu, D., Hu, B., Wang, R., Song, W., et al. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.100293 · Cited by 64
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
Ragotte, R. J., Pulido, D., Donnellan, F. R., Hill, M. L., Gorini, G., Davies, H. D., Brun, J., McHugh, K., King, L. D. W., Skinner, K., et al. (2021) · mSphere · doi:10.1128/msphere.00647-21 · Cited by 67
Souza, P. F. N., Mesquita, F. P., Amaral, J. L., Landim, P. G. C., Lima, K. R. P., Costa, M. B., Farias, I. R., Belém, M. O., Pinto, Y. O., Moreira, H. H. T., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.058 · Cited by 67
Kratzel, A., Kelly, J. N., V’kovski, P., Portmann, J., Brüggemann, Y., Tödt, D., Ebert, N., Shrestha, N., Plattet, P., Staab-Weijnitz, C. A., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001490 · Cited by 61
Planès, R., Bert, J.-B., Tairi, S., BenMohamed, L., & Bahraoui, E. (2022) · Viruses · doi:10.3390/v14050999 · Cited by 66
Wú, Z., Han, Y., Wang, Y., Liu, B., Zhao, L., Zhang, J., Su, H., Zhao, W., Liu, L., Bai, S., et al. (2022) · National Science Review · doi:10.1093/nsr/nwac213 · Cited by 64
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individualPreprint
Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.12.091298 · Cited by 64
Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
Hosoki, K., Chakraborty, A., & Sur, S. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.033 · Cited by 63
Yatoo, M. I., Hamid, Z., Parray, O. R., Wani, A. H., Haq, A. U., Saxena, A., Patel, S. K., Pathak, M., Tiwari, R., Malik, Y. S., et al. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1788310 · Cited by 64
Teralı, K., Baddal, B., & Gülcan, H. O. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107697 · Cited by 64
Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression
Cipolloni, L., Sessa, F., Bertozzi, G., Baldari, B., Cantatore, S., Testi, R., D’Errico, S., Mizio, G. D., Asmundo, A., Castorina, S., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10080575 · Cited by 63
ACE2 Protein Landscape in the Head and Neck Region: The Conundrum of SARS-CoV-2 Infection
Descamps, G., Verset, L., Trelcat, A., Hopkins, C. L., Lechien, J. R., Journé, F., & Saussez, S. (2020) · Biology · doi:10.3390/biology9080235 · Cited by 65
İdilman, İ. S., Dizman, G. T., Düzgün, S. A., Irmak, İ., Karçaaltıncaba, M., İnkaya, A. Ç., Demirkazık, F., Durhan, G., Akpınar, M. G., Arıyürek, O. M., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07155-3 · Cited by 62
Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System
Sparks, M. A., South, A. M., Badley, A. D., Baker-Smith, C. M., BATLLE, D. C., Bozkurt, B., Cattaneo, R., Crowley, S. D., Dell’Italia, L. J., Ford, A. L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15948 · Cited by 62
Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition
Allen, J. D., Watanabe, Y., Chawla, H., Newby, M. L., & Crispin, M. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.166762 · Cited by 65
The role of vaccines in the COVID-19 pandemic: what have we learned?
Krammer, F. (2023) · Seminars in Immunopathology · doi:10.1007/s00281-023-00996-2 · Cited by 66
Mao, T., Israelow, B., Suberi, A., Zhou, L., Reschke, M., Peña-Hernández, M. A., Dong, H., Homer, R. J., Saltzman, W., & Iwasaki, A. (2022) · bioRxiv · doi:10.1101/2022.01.24.477597 · Cited by 57
SARS‐CoV‐2 presence in seminal fluid: Myth or reality
Paoli, D., Pallotti, F., Turriziani, O., Mazzuti, L., Antonelli, G., Lenzi, A., & Lombardo, F. P. (2020) · Andrology · doi:10.1111/andr.12825 · Cited by 62
Bolcato, G., Bissaro, M., Pavan, M., Sturlese, M., & Moro, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-77700-z · Cited by 65
Recombination events are concentrated in the spike protein region of Betacoronaviruses
Bobay, L., O’Donnell, A. C., & Ochman, H. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009272 · Cited by 60
Therapeutic opportunities of edible antiviral plants for COVID-19
Patel, B. M., Sharma, S., Nair, N., Majeed, J., Goyal, R. K., & Dhobi, M. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04084-7 · Cited by 65
Saha, S., Rifai, R. H. A., & Saha, S. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00779-2 · Cited by 61
Awogbindin, I. O., Ben‐Azu, B., Olusola, B. A., Akinluyi, E. T., Adeniyi, P. A., Paolo, T. D., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.670298 · Cited by 61
Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion
Dodero‐Rojas, E., Onuchic, J. N., & Whitford, P. C. (2021) · eLife · doi:10.7554/elife.70362 · Cited by 62
Mohammad, T., Choudhury, A., Habib, I., Asrani, P., Mathur, Y., Umair, M., Anjum, F., Shafie, A., Yadav, D. K., & Hassan, M. I. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.765039 · Cited by 61
Metadata
- Authors
- Letko, M., Marzi, A., & Munster, V.
- Affiliations
- National Institutes of Health (US)
- National Institute of Allergy and Infectious Diseases (US)
- Corresponding author
- Letko, Michael
- Munster, Vincent
- Venue
- Nature Microbiology
- Published
- 2020-02-24
- Volume
- 5
- Issue
- 4
- Pages
- 562-569
- ISSN
- 2058-5276 (ISSN-L)
- PMC
- PMC7095430
- OpenAlex
- W3008394341
- Cited by
- 3,109
- References
- 38
- Citations by year
- 2026: 47 · 2025: 122 · 2024: 198 · 2023: 287 · 2022: 571 · 2021: 874 · 2020: 1002
- FWCI
- 89.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Microbiology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Chinese Center for Disease Control and Prevention
- Chinese Academy of Medical Sciences
- Peking Union Medical College
- National Institute of Allergy and Infectious Diseases
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
- Keywords
- SARS-CoV-2, SARS-CoV, cell entry, ACE2 receptor, zoonotic transmission, viral recombination, cross-species infection
- MeSH terms
- Protein Domains, Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Animals, Cell Line, Humans, Peptidyl-Dipeptidase A, Mutation, Pneumonia, Viral, Receptors, Virus, Recombinant Fusion Proteins, Trypsin, Coronavirus Infections, Dipeptidyl Peptidase 4, CD13 Antigens, Severe acute respiratory syndrome-related coronavirus, Virus Internalization, Pandemics, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
